Clinical trials
Completed Phase 4 Hepatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centers for Disease Control and Prevention | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
| Helsinki University Central Hospital | 1 |
| Kirby Institute | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| National Institute on Drug Abuse (NIDA) | 1 |
| Sanofi Pasteur, a Sanofi Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis | 16 |
| Hepatitis B | 4 |
| Hepatitis C | 3 |
| Hepatitis A | 2 |
| Hepatitis C, Chronic | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Anemia, Hemolytic | 1 |
| Encephalitis | 1 |
| Fatty Liver | 1 |
| Fibrosis | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.